Staff Profile
Dr Nina Wilson
Research Associate (statistician)
- Email: nina.wilson@ncl.ac.uk
- Telephone: 0191 208 4595
- Address: Population Health Sciences Institute
Faculty of Medical Sciences
Newcastle University
Baddiley-Clark Building
Richardson Road
Newcastle Upon Tyne
NE2 4AX
United Kingdom
Publications
- Maguire A, Clarkson JE, Douglas GVA, Ryan V, Homer T, Marshman Z, McColl E, Wilson N, Vale L, Robertson M, Abouhajar A, Holmes RD, Freeman R, Chadwick B, Deery C, Wong F, Innes NPT. Best-practice prevention alone or with conventional or biological caries management for 3- to 7-year-olds: the FiCTION three-arm RCT. Health Technology Assessment 2020, 24(1), 1-174.
- Innes NP, Clarkson JE, Douglas GVA, Ryan V, Wilson N, Homer T, Marshman Z, McColl E, Vale L, Robertson M, Abouhajar A, Holmes RD, Freeman R, Chadwick B, Deery C, Wong F, Maguire A. Child caries management: a randomized controlled trial in dental practice. Journal of Dental Research 2020, 99(1), 36-43.
- Homer T, Maguire A, Douglas G, Innes N, Clarkson J, Wilson N, Ryan V, McColl E, Robertson M, Vale L. Cost-effectiveness of child caries management: a randomised controlled trial (FiCTION trial). BMC Oral Health 2020, 20, 45.
- Mahil SK, Wilson N, Dand N, Reynolds NJ, Griffiths CEM, Emsley R, Marsden A, Evans I, Warren RB, Stocken D, Barker JN, Burden AD, Smith CH. Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR). British Journal of Dermatology 2020, 182(5), 1158-1166.
- Freeman R, Maguire A, Ryan V, Wilson N, Innes N, Clarkson J, McColl E, Marshman Z, Robertson M, Abouhajar A, Chadwick B, Deery C, Wong F, Douglas G. The FiCTION trial: child oral health related quality of life and dental anxiety across 3 treatment strategies for managing caries in young children. Community Dentistry and Oral Epidemiology 2020, 48(4), 328-337.
- Kunadian V, Wilson N, Stocken D, Hani A, McColl E, Burns G, Howe N, Fisher A, De Soyza A. Antiplatelet therapy in the primary prevention of cardiovascular diseasein patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial. ERJ Open Research 2019, 5(3).
- Tsakok T, Wilson N, Dand N, Loeff FC, Bloem K, Baudry D, Duckworth M, Pan S, Pushpa-Rajah A, Standing JF, De Vries A, Alsharqi A, Becher G, Murphy R, Wahie S, Wright A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, Burden AD, Rispens T, Stocken D, Smith C. Association of Serum Ustekinumab Levels with Clinical Response in Psoriasis. JAMA Dermatology 2019, 155(11), 1235-1243.
- Wilkinson N, Tsakok T, Dand N, Bloem K, Duckworth M, Baudry D, Pushpa-Rajah A, Griffiths CEM, Reynolds N, Barker J, Warren RB, Burden AD, Rispens T, Stocken D, Smith C, BSTOP study group, PSORT consortium. Defining the therapeutic range for adalimumab and predicting response in psoriasis: amulticenter prospective observational cohort study. Journal of Investigative Dermatology 2019, 139(1), 115-123.
- Mason KJ, Williams S, Yiu ZZN, McElhone K, Ashcroft DM, Kleyn CE, Jabbar-Lopez ZK, Owen CM, Reynolds NJ, Smith CH, Wilson N, Warren RB, Griffiths CEM. Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review. British Journal of Dermatology 2019, 181(2), 256-264.
- Rodgers H, Bosomworth H, Krebs HI, van Wijck F, Howel D, Wilson N, Aird L, Alvarado N, Andole S, Cohen DL, Dawson J, Fernandez-Garcia C, Finch T, Ford GA, Francis R, Hogg S, Hughes N, Price CI, Ternent L, Turner DL, Vale L, Wilkes S, Shaw L. Robot Assisted Training for the Upper Limb after Stroke (RATULS): a multi-centre randomised controlled trial comparing robot-assisted training; an enhanced upper limb therapy programme; and usual care. Lancet 2019, 394(10192), 51-62.
- Kunadian V, Chan D, Ali H, Wilkinson N, Howe N, McColl E, Thornton J, von Wilamowitz-Moellendorff A, Holstein EM, Burns G, Fisher A, Stocken D, De Soyza A. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronicobstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2). BMJ Open 2018, 8, e020713.
- Paleri V, Patterson J, Rousseau N, Moloney E, Craig D, Tzelis D, Wilkinson N, Franks J, Hynes AM, Heaven B, Hamilton D, Guerrero-Urbano T, Donnelly R, Barclay S, Rapley T, Stocken D. Gastrostomy versus nasogastric tube feeding forchemoradiation patients with head and neck cancer:the TUBE pilot RCT. Southampton: National Institute for Health Research (NIHR), 2018. Health Technology Assessment 12/35/32.
- McPherson S, Wilkinson N, Tiniakos D, Wilkinson J, Burt AD, McColl E, Stocken DD, Steen N, Barnes J, Goudie N, Stewart S, Bury Y, Mann D, Anstee QM, Day CP. A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis. PLoS One 2017, 12(4), e0175717.
- Dyson JK, Wilkinson N, Jopson L, Mells G, Bathgate A, Heneghan MA, Neuberger J, Hirschfield M, Ducker SJ, The UK-PBC Consortium, Sandford R, Alexander G, Stocken D, Jones DEJ. The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis. Alimentary Pharmacology & Therapeutics 2016, 44(10), 1039–1050.